tradingkey.logo
tradingkey.logo
Search

Tactile Systems Technology Inc

TCMD
Add to Watchlist
22.740USD
-0.300-1.30%
Close 05/15, 16:00ETQuotes delayed by 15 min
512.93MMarket Cap
25.79P/E TTM

Tactile Systems Technology Inc

22.740
-0.300-1.30%

More Details of Tactile Systems Technology Inc Company

Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company that manufactures and distributes medical devices for the treatment of patients with chronic diseases at home. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. It markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. It also offers Kylee, a free mobile application that helps patients learn about lymphedema.

Tactile Systems Technology Inc Info

Ticker SymbolTCMD
Company nameTactile Systems Technology Inc
IPO dateJul 28, 2016
CEODodd (Sheri L)
Number of employees1037
Security typeOrdinary Share
Fiscal year-endJul 28
Address3701 Wayzata Blvd, Suite 300
CityMINNEAPOLIS
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code55416
Phone18333822845
Websitehttps://www.tactilemedical.com/
Ticker SymbolTCMD
IPO dateJul 28, 2016
CEODodd (Sheri L)

Company Executives of Tactile Systems Technology Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Raymond O. (Ray) Huggenberger
Mr. Raymond O. (Ray) Huggenberger
Independent Director
Independent Director
62.84K
+10.38%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Chairman of the Board
Independent Chairman of the Board
55.04K
+11.85%
Ms. Elaine M. Birkemeyer
Ms. Elaine M. Birkemeyer
Chief Financial Officer
Chief Financial Officer
51.57K
-17.08%
Ms. Carmen B. Volkart
Ms. Carmen B. Volkart
Independent Director
Independent Director
44.22K
+14.75%
Ms. Sheri L. Dodd
Ms. Sheri L. Dodd
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Kristie T. Burns
Ms. Kristie T. Burns
Senior Vice President - Marketing and Clinical Affairs
Senior Vice President - Marketing and Clinical Affairs
--
--
Ms. Valerie L. (Val) Asbury
Ms. Valerie L. (Val) Asbury
Independent Director
Independent Director
--
--
Mr. D. Brent Shafer
Mr. D. Brent Shafer
Independent Director
Independent Director
--
--
Dr. B. Vindell Washington, M.D.
Dr. B. Vindell Washington, M.D.
Independent Director
Independent Director
--
--
Mr. Sam Bentzinger
Mr. Sam Bentzinger
Investor Relations Contact Officer
Investor Relations Contact Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Raymond O. (Ray) Huggenberger
Mr. Raymond O. (Ray) Huggenberger
Independent Director
Independent Director
62.84K
+10.38%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Chairman of the Board
Independent Chairman of the Board
55.04K
+11.85%
Ms. Elaine M. Birkemeyer
Ms. Elaine M. Birkemeyer
Chief Financial Officer
Chief Financial Officer
51.57K
-17.08%
Ms. Carmen B. Volkart
Ms. Carmen B. Volkart
Independent Director
Independent Director
44.22K
+14.75%
Ms. Sheri L. Dodd
Ms. Sheri L. Dodd
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Kristie T. Burns
Ms. Kristie T. Burns
Senior Vice President - Marketing and Clinical Affairs
Senior Vice President - Marketing and Clinical Affairs
--
--

Revenue Breakdown

Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2023
By BusinessUSD
Name
Revenue
Proportion
Lymphedema products
278.38M
84.48%
Airway clearance products
51.14M
15.52%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Lymphedema products
278.38M
84.48%
Airway clearance products
51.14M
15.52%

Shareholding Stats

Updated: Wed, May 13
Updated: Wed, May 13
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
6.83%
Morgan Stanley & Co. LLC
5.34%
Nomura Investment Management Business Trust
5.33%
Cadian Capital Management LP
4.81%
Dimensional Fund Advisors, L.P.
4.79%
Other
72.90%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
6.83%
Morgan Stanley & Co. LLC
5.34%
Nomura Investment Management Business Trust
5.33%
Cadian Capital Management LP
4.81%
Dimensional Fund Advisors, L.P.
4.79%
Other
72.90%
Shareholder Types
Shareholders
Proportion
Investment Advisor
43.16%
Investment Advisor/Hedge Fund
38.32%
Hedge Fund
10.28%
Research Firm
7.16%
Individual Investor
2.33%
Pension Fund
0.69%
Bank and Trust
0.42%
Family Office
0.31%
Venture Capital
0.10%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
376
24.21M
107.32%
-2.56M
2025Q4
351
22.70M
101.64%
-5.48M
2025Q3
366
22.60M
101.18%
-8.77M
2025Q2
389
24.67M
110.65%
-7.05M
2025Q1
401
24.00M
103.20%
-7.47M

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
1.54M
6.77%
-82.94K
-5.11%
Dec 31, 2025
Morgan Stanley & Co. LLC
1.20M
5.3%
-913.29K
-43.12%
Dec 31, 2025
Nomura Investment Management Business Trust
1.20M
5.29%
--
--
Mar 09, 2026
Cadian Capital Management LP
1.08M
4.77%
-971.66K
-47.27%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
1.10M
4.81%
-95.97K
-8.06%
Dec 31, 2025
Acadian Asset Management LLC
956.07K
4.2%
+110.62K
+13.08%
Dec 31, 2025
Paradigm Capital Management, Inc.
736.60K
3.24%
-801.80K
-52.12%
Dec 31, 2025
Arrowstreet Capital, Limited Partnership
638.37K
2.81%
+529.37K
+485.65%
Dec 31, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Cambria Micro and SmallCap Shareholder Yield ETF
1.13%
Invesco NASDAQ Future Gen 200 ETF
0.61%
First Trust Active Factor Small Cap ETF
0.61%
Lattice Hartford Multifactor Small Cap ETF
0.58%
Federated Hermes MDT Small Cap Core ETF
0.38%
Unusual Whales Subversive Democratic Trading ETF
0.37%
iShares US Small Cap Value Factor ETF
0.33%
Royce Quant Small-Cap Quality Value ETF
0.21%
Vanguard US Multifactor ETF
0.14%
VictoryShares Small Cap Free Cash Flow ETF
0.12%
View more
Cambria Micro and SmallCap Shareholder Yield ETF
Proportion1.13%
Invesco NASDAQ Future Gen 200 ETF
Proportion0.61%
First Trust Active Factor Small Cap ETF
Proportion0.61%
Lattice Hartford Multifactor Small Cap ETF
Proportion0.58%
Federated Hermes MDT Small Cap Core ETF
Proportion0.38%
Unusual Whales Subversive Democratic Trading ETF
Proportion0.37%
iShares US Small Cap Value Factor ETF
Proportion0.33%
Royce Quant Small-Cap Quality Value ETF
Proportion0.21%
Vanguard US Multifactor ETF
Proportion0.14%
VictoryShares Small Cap Free Cash Flow ETF
Proportion0.12%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI